Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?

Circulation. 2022 Oct 18;146(16):1207-1209. doi: 10.1161/CIRCULATIONAHA.122.061987. Epub 2022 Aug 27.

Ying X Gue¹, Diana A Gorog^{2

3}, Gregory Y H Lip^{1

4}

¹ Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom (Y.X.G., G.Y.H.L.).
² School of Life and Medical Sciences, Postgraduate Medical School, University of Hertfordshire, United Kingdom (D.A.G.).
³ Faculty of Medicine, National Heart and Lung Institute, Imperial College, London, United Kingdom (D.A.G.).
⁴ Department of Clinical Medicine, Aalborg University, Denmark (G.Y.H.L.).

No abstract available

Keywords: Editorials; acute coronary syndrome; factor XIa; hemorrhage.

Publication types